06 Nov 2018 by admin in UncategorizedComments Crescendo Biologics wins “Biotech Company of the Year” at the Cambridge Independent Science and Technology Awards 2018
05 Nov 2018 by admin in UncategorizedComments Crescendo Biologics announces early licensing by Takeda of first oncology-targeted Humabody®
16 Oct 2018 by admin in UncategorizedComments Centrexion Therapeutics Announces Two CNTX-4975 Presentations at the 2018 American College of Rheumatology Annual Meeting
08 Oct 2018 by admin in UncategorizedComments Crescendo Biologics appoints SVP CMC, Dr Richard Williams, and new CDMO partner, as it advances towards the clinic
02 Oct 2018 by admin in UncategorizedComments Crescendo Biologics shortlisted for Private Financing Deal of the Year at 2018 Scrip Awards
24 Sep 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Andrew Partridge as Executive Vice President, Chief Commercial Officer
24 Sep 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Andrew Partridge as Executive Vice President, Chief Commercial Officer
20 Sep 2018 by admin in UncategorizedComments Crescendo Biologics shortlisted for Lifestars Awards 2018
19 Sep 2018 by admin in UncategorizedComments Crescendo Biologics shortlisted for Cambridge Independent Science and Technology Awards 2018
18 Sep 2018 by admin in UncategorizedComments resTORbio Appoints Meredith Manning as Chief Commercial Officer
